Success Story: South Korean Researcher Secures NIW Approval for Work Expanding the Practical Value of Health Data
Client’s Testimonial:
"I really appreciate all your help throughout the process! Thanks again to my attorney and the entire team for the excellent support.”
On March 19th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Biomedical Informatics (Approval Notice).
General Field: Biomedical Informatics
Position at the Time of Case Filing: Researcher
Country of Origin: South Korea
Country of Residence at the Time of Filing: South Korea
Approval Notice Date: March 19th, 2026
Processing Time: 3 months, 26 days (Premium Processing Requested)
Case Summary:
Originally from South Korea, our client worked as a researcher and built a professional profile around advanced computational and data science methods for large-scale clinical and biomedical datasets. Her work focused on real-world data and its applications in healthcare research and improving clinical outcomes.
Her academic background reflected the interdisciplinary nature of that work. Her degrees combine technical training in quantitative analysis with expertise in healthcare-oriented data applications. North America Immigration Law Group (Chen Immigration Law Associates) used this foundation to show how well-positioned she was to continue contributing to research that connects data science, medicine, and health system improvement.
Her record of achievement gave strong support to that narrative. She had documented her scholarly work in:
- 6 peer-reviewed journal articles
- 3 peer-reviewed conference articles
- 11 abstracts
- 3 granted patents
Her influence was also reflected in the response from the wider research community. The petition documented 224 citations to her published work and noted that 3 of her papers ranked among the top 10% most-cited articles for their publication years, while 2 more ranked among the top 20%. These numbers mattered because they showed that other researchers were not merely aware of her findings but were actively using them in their own work.
That independent use could be seen across multiple disciplines. Later studies relied on her foundational research to support and validate emerging methodologies, while other scholars drew on her diverse project work to inform broader technological and policy studies. This breadth of downstream reliance reinforced the point that her contributions had already begun shaping conversations across her field and related areas of applied science.
We demonstrated that her continued work would serve the national interest. We are delighted by this NIW approval and look forward to her future contributions to biomedical informatics, precision medicine, and the smarter use of health data.